ATPIF1 inactivation promotes antitumor immunity through metabolic reprogramming of CD8+ T cells
G. Zhong, Y. Wang, J. Zhang…·J. Ye
This study shows that inactivating ATPIF1 enhances CD8+ T cell antitumor activity by reprogramming their metabolism, leading to better tumor suppression in mouse models.